Some of the scientific groundwork that paved the way for a rebirth of the long-extinct dire wolf took place in Pennsylvania.

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

Newco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes.

Brazilian Fish has set out its plans to use the latest genetic technology to improve its farmed tilapia, with the help of US ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Editas Medicine, Inc.’s EDIT share price has dipped by 5.16%, which has investors questioning if this is right time to buy.

Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf ...

In a major breakthrough, a team at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) found a new way to acccelerate plant bioengineering using robots. Researchers deployed a ...

Silicon Valley-based law firm Fenwick & West LLP is expanding its East Coast footprint with the launch of a new Boston office ...

A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...